Metagenics will appeal Bone Builder ruling by FTC judge.
This article was originally published in The Tan Sheet
Executive Summary
METAGENICS BONE BUILDER CLAIMS: COMPANY WILL APPEAL FTC RULING that the firm's data fail to uphold bone restoration claims, bone ailment-related pain reduction claims or superiority claims for its Bone Builder calcium supplement. The ruling, handed down by Federal Trade Commission Administrative Law Judge Lewis Parker Oct. 11, was announced by Clemente, Calif.-based Metagenics on Oct. 29.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning